Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Mar;8(1):CNS26.
doi: 10.2217/cns-2018-0019. Epub 2019 Feb 15.

How far will the Voyager® take us?

Victor A Levin  1   2   3
Affiliations
Editorial

How far will the Voyager® take us?

Victor A Levin. CNS Oncol. 2019 Mar.
No abstract available

Keywords: PD-1 inhibitor; electromagnetic fields; glioblastoma; paclitaxel mimic.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The author is the Founder and Senior Medical Adviser for Orbus Therapeutics, DMC Chair for Bristol-Myers Squibb clinical trials and a member of SAB for Nativis, Inc.

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Comment on

Similar articles

See all similar articles

Cited by

  • Welcome to Volume 9 of CNS Oncology.
    Straiton J. Straiton J. CNS Oncol. 2020 Mar 1;9(1):CNS49. doi: 10.2217/cns-2019-0023. Epub 2020 Mar 2. CNS Oncol. 2020. PMID: 32118489 Free PMC article. No abstract available.

References

    1. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
    1. Cohen AL, Colman H. Glioma biology and molecular markers. Cancer Treat. Res. 2015;163:15–30. - PubMed
    1. Tanguturi SK, Trippa L, Ramkissoon SH, et al. Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma. Neuro-oncology. 2017;19(7):908–917. - PMC - PubMed
    1. Sulman EP, Ismaila N, Armstrong TS, et al. Radiation therapy for glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. J. Clin. Oncol. 2017;35(3):361–369. - PubMed
    1. Bell EH, Pugh SL, McElroy JP, et al. Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era: a correlative analysis based on NRG oncology RTOG 0525. JAMA Oncol. 2017;3(6):784–792. - PMC - PubMed